Skip to Content

Eprosartan Side Effects

For the Consumer

Applies to eprosartan: oral tablet

In addition to its needed effects, some unwanted effects may be caused by eprosartan. In the event that any of these side effects do occur, they may require medical attention.

Major Side Effects

You should check with your doctor immediately if any of these side effects occur when taking eprosartan:

Less common:
  • Burning or painful urination or changes in urinary frequency
  • cough
  • fever
  • sore throat
  • Dizziness, lightheadedness, or fainting
  • swollen face, lips, limbs, or tongue

Minor Side Effects

Some of the side effects that can occur with eprosartan may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Less common or rare:
  • Abdominal or stomach pain
  • joint pain
  • unusual tiredness

For Healthcare Professionals

Applies to eprosartan: oral tablet


The most common adverse reactions were headache and unspecific gastrointestinal complaints.[Ref]

Nervous system

Very common (10% or more): Headache (up to 11%)
Common (1% to 10%): Dizziness
Frequency not reported: Ataxia, migraine, neuritis, paresthesia, somnolence, tremor, vertigo, tinnitus[Ref]


Common (1% to 10%): Unspecific gastrointestinal complaints, abdominal pain, diarrhea, dyspepsia
Frequency not reported: Constipation, dry mouth, esophagitis, flatulence, gastritis, gastroenteritis, gingivitis, nausea, periodontitis, toothache, vomiting[Ref]


Common (1% to 10%): Rhinitis, upper respiratory tract infection, pharyngitis, coughing, sinusitis, dyspnea, bronchitis
Frequency not reported: Asthma, epistaxis[Ref]


Common (1% to 10%): Asthenia, injury, chest pain, fatigue, pain
Uncommon (0.1% to 1%): Facial edema
Frequency not reported: Substernal chest pain, peripheral edema, fever, influenza-like symptoms, malaise[Ref]


Common (1% to 10%): Myalgia, arthralgia, back pain
Frequency not reported: Rigors, creatine phosphokinase increased, arthritis, arthritis aggravated, arthrosis, skeletal pain, tendinitis, leg cramps[Ref]


Common (1% to 10%): Palpitation, dependent edema
Uncommon (0.1% to 1%): Hypotension
Frequency not reported: Hot flushes, angina pectoris, bradycardia, ECG abnormal, ECG specific abnormal, extrasystoles, atrial fibrillation, tachycardia, peripheral ischemia[Ref]


Common (1% to 10%): Neutrophils 1500/mm3 or less
Uncommon (0.1% to 1%): Hemoglobin decreased greater than 20%, WBC count of 3000/mm3 or less, platelets 100 x 10(9)/L or less
Frequency not reported: Anemia, leukopenia[Ref]


Common (1% to 10%): Hypertriglyceridemia
Uncommon (0.1% to 1%): Potassium 5.6 mmol/L or greater
Frequency not reported: Alcohol intolerance, anorexia, diabetes mellitus, gout, hypercholesterolemia, hyperglycemia, hyperkalemia, hypokalemia, hyponatremia[Ref]


Common (1% to 10%): Allergic skin reactions
Uncommon (0.1% to 1%): Angioedema
Frequency not reported: Purpura, eczema, furunculosis, pruritus, rash, maculopapular rash, sweating increased[Ref]


Common (1% to 10%): Viral infection
Uncommon (0.1% to 1%): Hypersensitivity
Frequency not reported: Herpes simplex, otitis externa, otitis media[Ref]


Common (1% to 10%): BUN increased
Uncommon (0.1% to 1%): Creatinine increased
Frequency not reported: Renal calculus
Postmarketing reports: Impaired renal function, renal failure[Ref]


Common (1% to 10%): Urinary tract infection
Frequency not reported: Glycosuria, albuminuria, cystitis, hematuria, micturition frequency, polyuria, urinary incontinence[Ref]


Common (1% to 10%): Depression
Frequency not reported: Anxiety, insomnia, nervousness[Ref]


Uncommon (0.1% to 1%): ALT greater than 3.5 times the upper limit of normal
Frequency not reported: Serum glutamic oxaloacetic transaminase (SGOT) increased, serum glutamic pyruvic transaminase (SGPT) increased, ALT increased, AST increased, alkaline phosphatase increased[Ref]


Frequency not reported: Conjunctivitis, vision abnormal, xerophthalmia[Ref]


1. Cerner Multum, Inc. "Australian Product Information." O 0

2. "Product Information. Teveten (eprosartan)." SmithKline Beecham, Philadelphia, PA.

3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Not all side effects for eprosartan may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.